Evidence map›Paper›PMID 33489041›Full record

ArticleMediterranean journal of hematology and infectious diseases2021

Prevalence of Serious Bacterial Infections in Children with Sickle Cell Disease at King Abdulaziz Hospital, Al Ahsa.

Manal A Alsaif, Moshtag Abdulbaqi, Khalid Al Noaim, Mustafa Aghbari, Muneera Alabdulqader, Joan L Robinson

Abstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manal A AlsaifDepartment of Pediatrics, King, Abdulaziz Hospital, King Abdullah International Medical Research Center, Al-Ahsa, Saudi Arabia.
Moshtag AbdulbaqiDepartment of Pediatrics, King, Abdulaziz Hospital, King Abdullah International Medical Research Center, Al-Ahsa, Saudi Arabia.
Khalid Al NoaimDepartment of Pediatrics, King Faisal University, College of Medicine, Al-Ahsa, Saudi Arabia.
Mustafa AghbariDepartment of Pediatrics, King, Abdulaziz Hospital, King Abdullah International Medical Research Center, Al-Ahsa, Saudi Arabia.
Muneera AlabdulqaderDepartment of Pediatrics, King Faisal University, College of Medicine, Al-Ahsa, Saudi Arabia.
Joan L RobinsonDepartment of Pediatrics, University of Alberta, Edmonton, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe main aim was to report the prevalence and severity of serious bacterial infections (SBI) in children with sickle cell disease at King Abdulaziz Hospital (KAH), Al Ahsa, Saudi Arabia, to aid in determining whether outpatient management of such cases is appropriate.

methodsWe conducted a retrospective chart review of febrile children less than 14 years of age admitted with sickle cell disease 2005 through 2015.

resultsDuring 320 admissions, 25 children had SBIs (8%) including pneumonia (n=11), osteomyelitis (n=8), bacteremia (n=3, all with

conclusionIt appears that in the current era, less than 10% of febrile children with sickle cell disease in our center are diagnosed with an SBI. Over 11 years, there were no sequelae or deaths from SBI. Given these excellent outcomes, outpatient ceftriaxone should be considered for febrile well-appearing children with sickle cell disease if they have no apparent source and parents are judged to be reliable.

Indexed as

BacteremiaOsteomyelitisPneumoniaSerious bacterial infectionSickle cell disease

Identifiers

PMID33489041
PMCPMC7813273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.